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QUANTITY: An Isobaric Tag for 
Quantitative Glycomics
Shuang Yang1,*, Meiyao Wang2,6, *, Lijun Chen1, Bojiao Yin3, Guoqiang Song4, 
Illarion V. Turko2,5, Karen W. Phinney5, Michael J. Betenbaugh3, Hui Zhang1 & Shuwei Li2
Glycan is an important class of macromolecules that play numerous biological functions. Quantitative 
glycomics - analysis of glycans at global level - however, is far behind genomics and proteomics 
owing to technical challenges associated with their chemical properties and structural complexity. 
As a result, technologies that can facilitate global glycan analysis are highly sought after. Here, 
we present QUANTITY (Quaternary Amine Containing Isobaric Tag for Glycan), a quantitative 
approach that can not only enhance detection of glycans by mass spectrometry, but also allow 
high-throughput glycomic analysis from multiple biological samples. This robust tool enabled us to 
accomplish glycomic survey of bioengineered Chinese Hamster Ovary (CHO) cells with knock-in/out 
enzymes involved in protein glycosylation. Our results demonstrated QUANTITY is an invaluable 
technique for glycan analysis and bioengineering.
Glycans (a.k.a. carbohydrate or polysaccharide) are an important class of biomolecules that play crit-
ical roles in biological processes such as protein trafficking, cell-to-cell communication and immune 
responses, and their abnormality could be associated with numerous diseases including cancer, dementia, 
and autoimmune disorders1,2. The potency and stability of therapeutic biological drugs like monoclonal 
antibodies are also affected by glycans they carry3. As a result, understanding glycan functions is of 
great significance in academic research, pharmaceutical industry and healthcare4. However, the progress 
on glycan research is far behind other biomolecules like nucleic acids and proteins because of technical 
challenges associated with their unique chemical properties and structural complexity5.
To assist structural analysis, glycans are usually derivatized (e.g. fluorescence tags like 2-aminobenzamide 
(2-AB) or 2-aminobenzoic acid (2-AA), permethylation, etc.) to improve their characterization on var-
ious analytical platforms, including capillary electrophoresis (CE), liquid chromatography (LC), mass 
spectrometry (MS), and so on6. MS has become one of the most popular tools for glycan analysis mainly 
because of its ability to determine glycan compositions even from overlapping peaks and its compatibility 
with other methods (e.g. RapFluor-MS7). Meanwhile, stable isotope labels have also gained increasingly 
popularity as they allow accurate quantification of glycans using MS.
There are two major types of stable isotope labeling approaches, mass shift and isobaric tags, both 
of which have been extensively used for the quantification of proteins8–10 and small molecules such as 
metabolites11,12. A primary difference between mass shift and isobaric tags is that quantitation of a mass 
shift tag is achieved in MS1 while isobaric quantification relies on reporter ions generated in MS2 or 
MS3. Despite multiple advantages offered by isobaric tags, such as allowing quantification of up to ten 
samples in a single assay13 and increasing detection limit by accumulating signals from multiple sam-
ples together, there are very few successes to develop isobaric tags for glycan quantification. In fact, to 
our best knowledge, only two isobaric tags, aminoxyTMT14 and iART15 from our own work, have been 
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applied for glycan quantification and shown limited success. One of reasons is that both isobaric tags 
were based on a tertiary amine structure that was originally designed for peptide quantification and 
fragments less favorably than glycosidic bonds in MS2. Therefore, neither aminoxyTMT nor iART can 
generate reporter ions strong enough for accurate quantification of labeled glycans, especially for high 
molecular weight glycans.
Here, we report a novel type of isobaric tags capable of fragmenting as easily as glycosidic bonds, 
which is based on our serendipitous discovery that a quaternary amine can easily lose one of its four sub-
stituents on nitrogen upon MS2 fragmentation. The tags, termed Quaternary Amine Containing Isobaric 
Tag for Glycan (QUANTITY), can completely label glycans and generate strong reporter ions. Up to four 
samples can be labeled and analyzed concurrently for the relative quantification of glycans. To demon-
strate the application of QUANTITY, we examined the protein N-glycosylation of several genetically 
engineered Chinese Hamster Ovary (CHO) cell lines, in which one of glycosyltransferases was either 
knocked in or knocked out. To our best knowledge, this is the first quantitative glycomic analysis of 
engineered CHO cells. Since CHO cells are used for the production of monoclonal antibodies in the 
pharmaceutical industry, our results would pave a way for the better understanding of glycosylation on 
therapeutic proteins and lead to more potent biological drugs with desirable pharmaceutical properties.
Results
Design of QUANTITY. As other isobaric tags for peptides and small molecules, the 4-plex QUANTITY 
reagents are a set of four molecules with identical chemical structures and molecule weight, yet they 
contain different stable isotope nuclei like 13C and 2H in various positions (Synthesis of QUANTITY 
is described in Supporting Materials Figures S1&2). Their structures consist of a reporter with molec-
ular mass ranging from 176 to 179 Daltons in the series, a balancer that compensates the mass differ-
ence of the reporters, and a reactive primary amine to conjugate with glycans via reductive amination 
(Fig. 1). This labeling chemistry is the same as that used by 2-AA/2-AB16, so well-established protocols 
for 2-AA/2-AB labeling can be applied without much modification. A noticeable difference between 
our tags and 2-AA/2-AB, however, is that a water molecule is lost spontaneously and stoichiometrically 
from QUANTITY-labeled glycans, while 2-AA/2-AB labeled glycans only show the partial loss of a water 
molecule17. This phenomenon might be proceeded through an energetically favored six-membered ring 
formation in a neighboring group participation mechanism (a.k.a. neighboring participation reaction)18. 
Upon MS2 fragmentation, QUANTITY-labeled glycans yield strong reporter ions for accurate quantifica-
tion without the need of extra positive ions such as Na+ or metal ions, thereby eliminating ion suppres-
sion effect and preventing the formation of multiple H+/Na+ adducts. Furthermore, outfitting glycans 
with a permanently positive-charged quaternary amine can enhance their ionization in MS. Therefore, 
the detection sensitivity of glycans is considerably enhanced, which is advantageous when analyzing low 
abundance glycans or limited samples.
To apply QUANTITY for glycan analysis, we have developed a solid-phase based protocol (Fig. 1)15. 
Glycoproteins are first immobilized on beads and treated with excess p-toluidine (pT) in the presence of 
a carbodiimide coupling reagent. This step can completely conjugate sialic acids on glycans with pT to 
stabilize these labile residues during MS analysis. N-glycans are then released from the immobilized gly-
coproteins with PNGase F, resulting in an exposed aldehyde group at their reducing end for QUANTITY 
labeling. The labeled glycans are then analyzed with reverse phase liquid chromatography (RPLC) cou-
pled with tandem MS. A bonus of this protocol is that a hydrophobic pT moiety is coupled to each sialic 
acid, so N-glycans carrying different number of sialic acids can be easily resolved on a C18 column.
The monoisotopic mass of a labeled glycan, M = FaNbHcSdGe, is calculated based on Equation 1.
= + × + × + × + × + × + ( + ) × + ( )M C a F b N c H d S e G d e pT Q 1
Here: C stands for N-glycan core structure, 910.3278 Da; F is fucose, 146.0579 Da; N is HexNAc, 
203.0794 Da; H is Hexose, 162.0528 Da; S is Neu5Ac, 291.0954 Da; G is Neu5Gc, 307.0903 Da; pT is 
p-Toluidine, 89.0629 Da (after the loss of one water), which is coupled to each sialic acid in our protocol; 
Q is QUANTITY, 233.2147 Da (after the loss of one oxygen due to reductive amination and the loss of 
one water due to neighboring participation reaction); a, b, c, d, and e is the number of each respective 
unit. It is important to note that the core structure (2 HexNAc and 3 Hexose) is excluded from the for-
mula (FaNbHcSdGe) of N-glycans throughout this report. In other words, b and c represent the HexNAc 
and Hexose units other than those in the core structure, respectively.
In ESI, a labeled glycan is usually detected as an ion carrying multiple charges (Z) with observed m/z 
as B. We can calculate its monoisotopic mass (M′ ) based on Equation 2.
= × + ( − . ) ( )′M B Z Z 1 0078 2
To identify a glycan from an MS experiment, we can first calculate the monoisotopic mass (M) of all 
QUANTITY labeled N-glycans in a glycan library, such as Consortium for Functional Glycomics (CFG) 
database. Then, we can calculate the monoisotopic mass (M′ ) of an ion in an MS1 spectrum and match 
with the monoisotopic mass (M) calculated from the glycan database to determine its composition.
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Performance of QUANTITY. We first demonstrated the completion of QUANTITY labeling. Two 
N-glycans (N2H2S2 > 90%, and N2H2S < 10%) extracted from 1 mg standard sialylglycopeptide (SGP) 
were labeled with QUANTITY-176 (30 μ L at 40 mM) in 70% dimethyl sulfoxide (DMSO) and 30% acetic 
acid (HOAc) containing 1 M sodium cyanoborohydride (NaCNBH3). As a comparison, the SGP gly-
cans were also labeled by a commercially available isobaric tag for glycans based on tertiary amine 
(aminoxyTMT-126) similarly. Figure 2 shows the MS1 (a & b) and MS2 (c) of QUANTITY-labeled SGP 
glycans, as well as the MS1 (d & e) and MS2 (f) of aminoxyTMT labeled counterparts acquired on an ESI 
instrument (their MALDI MS1 spectra, together with the MALDI MS1 of unlabeled SGP glycans, are also 
available in Figure S4). The QUANTITY-labeled glycans only show two dominant peaks as labeled N2H2S 
and N2H2S2, indicating the labeling reaction was completed. Although aminoxyTMT-labeled glycans also 
show two major peaks, we still observed unlabeled N2H2S and N2H2S2, suggesting the labeling reaction 
with aminoxyTMT was more difficult to complete. In addition, the aminoxyTMT labeled glycans dis-
play multiple satellite peaks with 14 Dalton mass difference (Fig.  2e), making MS1 more complex and 
Figure 1. QUANTITY isobaric tandem mass tags for glycan labeling and quantitation. (a) Molecular 
structure and isotope positions of QUANTITY. (b) N-acetylglucosamine (GlcNAc, the first residue on the 
reducing end of N-glycans) labeled with QUANTITY and its fragmentation in MS2. A water molecule is 
lost during labeling, probably through a six-membered ring formation (neighboring group participation 
reaction). The arrow indicates fragmentation site in MS2. (c) Workflow of N-glycan extraction from solid-
phase for labeling of N-glycans by isobaric tandem mass tags and analysis of peptide using LC-MS/MS. 
Proteins are immobilized on beads via reductive amination. Sialic acids are stabilized via carbodiimide 
coupling. The released N-glycans by PNGase F are labeled with QUANTITY. The global proteins are further 
analyzed by direct digestion from beads.
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averaging out peak intensity. More significantly, when the labeled glycans were fragmented, the reporter 
ion (m/z 176.11) generated from the quaternary amine of QUANTITY yields decent signal in compari-
son to common glycan fragment ions (m/z 138.05 or 204.09). In contrast, the reporter ion (m/z 126.11) 
generated from the tertiary amine of aminoxyTMT not only shows much less intensity, but is susceptible 
to the interference from a glycan fragment (m/z 126.05) (Fig. 2c,f). This experiment clearly demonstrated 
the completion of QUANTITY labeling and its advantages over the existing isobaric tags for glycans.
Next, we tested the quantification accuracy of QUANTITY by labeling fetuin N-glycans with 4-plex 
QUANTITY at a ratio of 1:1:3:5. Fetuin proteins from fetal bovine (200 μ g, 200 μ g, 600 μ g, and 1000 μ g; 
triplicates) were processed by following our standard protocol. Figure 3a shows the MS1 of QUANTITY 
labeled fetuin N-glycans, including N2H2S2, N3H3S2, N3H3S3, and N3H3S4. Figure  3b is a representative 
full MS2 spectrum (N2H2S2), which includes a series of glycan fragments for easy structural elucidation 
of the precursor ion and strong reporter ions ranging from 176 to 179. The inset is the expanded low 
mass range of the MS2 showing the signal of each reporter ion, which indicates the relative abundance 
of glycans from four original samples. The experimental result of this glycan (N2H2S2) is very close 
to 1:1:3:5 (Fig.  3c). The linear correlation between the measured and theoretical ratios and the small 
standard deviation from three independent replicates indicate the great reproducibility of QUANTITY 
quantification (the quantification of other glycans is provided in the supporting information Table S1).
We then tested whether QUANTITY can be applied for complex biological samples. N-Glycans from 
20 μ L human serum were extracted and labeled with QUANTITY completely. A quick survey with 
MALDI-MS showed the profiling of serum N-glycans after QUANTITY labeling was very similar to that 
of unlabeled native N-glycans (Figure S5), whereas a more detailed analysis with RPLC-MS allowed us 
to identify over 90 N-glycans from serum (Table S3). We provide an example on how to assign a glycan 
structure based on its precursor mass and MS2 fragments (Table S2 and Figure S6). Clearly, QUANTITY 
is a robust and sensitive approach for glycan analysis from complex biological specimens.
Glycomic Investigation on Bioengineered CHO Cells. In 2014, seven of the ten best-selling drugs 
are recombinant proteins that treat various conditions including cancer, diabetes and arthritis. These 
therapeutic proteins, especially monoclonal antibodies, are usually modified with N-glycans, which have 
profound impact on their efficacy and stability. CHO cells are widely used for the production of these 
biological drugs since they can produce glycoproteins compatible with humans and glycosylation can also 
be manipulated through genetic engineering19,20. It is well known that the modification of glycan biosyn-
thetic pathways can alter the size of the glycans and the sites available for sialic acid attachment, which 
are associated with circulatory half-life of many therapeutic glycoproteins like erythropoietin (EPO)21,22. 
Therefore, it is of great significance for biopharmaceutical industry to investigate protein glycosylation 
on normal and genetically engineered CHO cells. To demonstrate the feasibility of QUANTITY for this 
important application, we quantitatively analyzed N-glycans from three different CHO cells, including 
Figure 2. Comparison of N-glycan labeling by QUANTITY and aminoxyTMT-126 (TMT). Standard 
sialylglycopeptide (SGP) was used for labeling via reduction amination (1M NaCHBH3, DMSO:HOAc = 7:3, 
65 °C/4h). SGP has two sialic acids including N2H2S and N2H2S2. (a) Full MS spectrum of SGP-QUANTITY. 
(b) MS1 spectrum of N2H2S2-QUANTITY. (c) MS2 reporter ions of N2H2S2-QUANTITY. (d) Full MS 
spectrum of SGP-TMT. (e) MS1 spectrum of N2H2S2-TMT, several by-products observed after aminoxyTMT 
labeling. (f) MS2 reporter ions of N2H2S2-TMT.
www.nature.com/scientificreports/
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wild-type CHO-K1 (WT), CHO-K1 with a knock-in ST6Gal1 gene (ST6Gal1(+ )), and CHO-K1 with 
a knock-out ST3Gal4 gene (ST3Gal4(-)). ST6Gal1 and ST3Gal4 represent ST6 beta-galactosamide 
alpha-2,6-sialyltranferase 1 and ST3 beta-galactoside alpha-2,3-sialyltransferase 4 respectively, both of 
which belong to the glycosyltransferase 29 family that is involved in protein glycosylation.
We cultured three cell lines in F12-K medium with fetal bovine serum, except for ST6Gal1(+ ) in 
which blasticidin was also included. Glycans extracted from these cells were analyzed by using our 
standard solid phase based protocol (Figure S8)23. Most QUANTITY-labeled glycans exhibited multiple 
charges (+ 2 and + 3) and gave satisfactory MS2 fragments for structural determination (Fig. 4a,c). After 
all precursor ions were extracted as singly-charged peaks by Thermo Xcalibur-Xtract (Fig.  4b), each 
glycan only consisted of a single species and no metal adducts were observed. This feature, unique to 
QUANTITY-labeled glycans, was significant in that glycans could otherwise form multiple metal adducts 
that average out their intensity to more species and reduce their detection sensitivity. Figure  4c is the 
representative full MS2 spectrum of N2H2S showing strong signal on reporter ions for its quantification 
and distinct large fragments for its structural identification. The reporter ions of several other glycans, 
including FN2H2S2 (2782.2), N2H2S2 (2635.1), N3H3S3 (3380.4), and N5H4S4 (4329.0), are also shown in 
Fig. 4d.
A complete list of N-glycans from CHO (WT, ST6Gal1(+ ), and ST3Gal4(−)) is provided (Fig.  5, 
Table S4 and Figure S8 & S9). Lectin blot confirmed the up-regulation of sialic acids in ST6Gal1 (+ ) 
and the partial down-regulation of sialic acids in ST3Gal4 (−) (Fig. 5a). A total of 159 N-glycans were 
quantitatively analyzed, in which 114 (71.2%) of the N-glycans were up-regulated in ST6Gal1(+ ). These 
over-expressed N-glycans had a greater number of terminal sialic acids, as depicted in the heatmap 
(Fig. 5b). The most abundant sialylated glycans, including N2H2S, N2H2S2, FN2H2S2, are over-expressed 
in ST6Gal1(+ ) while down-regulated in ST3Gal4(−) as expected (Fig.  5c–e). In addition, 44 glycans 
were only detected in ST6Gal1(+ ) compared to WT, such as FN5H5S6. In contrast, only 22 (13.8%) gly-
cans were down-regulated in ST3Gal4(−). Three of them (FN2H2S3, FH3, and FN3HS) were completely 
absent in ST3Gal4(−), while the other 19 glycans (e.g. N3H3S, N2H2S2, FN2H2S2, and FN6H2) were only 
down-regulated, probably because other enzymes partially compensate the lost ST3Gal4 activity. These 
results indicate that protein glycosylation in CHO cells can be significantly modified by regulating the 
expression of a large family of genes that are involved in glycan biosynthesis. This can not only provide a 
powerful means to quantitatively investigate the in vivo functions of these enzymes, but also lead to engi-
neered CHO cells for the production of therapeutic proteins with desirable pharmaceutical properties.
Figure 3. Efficiency and linear range of glycan labeling with QUANTITY. N-Glycans extracted from 
bovine fetuin are prepared in a ratio of 1:1:3:5 prior to labeling with QUANTITY via reduction amination. 
The labeled fetuin glycans (m/z at 176, 177, 178, and 179), sialylated glycans, including N2H2S2, N3H3S2, 
N3H3S3, and N3H3S4, are pooled for electrospray (ESI) – tandem mass spectrometry (MS2) (note: core 
structure N2H3 is not included in the composition). (a) MS spectrum of fetuin N-glycans. (b) MS2 spectra 
of N2H2S2 consist of glycan fragmentation and QUANTITY reporter ions. (c) Linear range of glycan-
QUANTITY labeling at a ratio of 1:1:3:5. Error bar were obtained from three independent experiments.
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Discussion
QUANTITY is the first quaternary amine based isobaric tag for glycan quantification and uses the 
same chemistry as popular 2-AA/2-AB. Because quaternary amine is permanently positive-charged, 
QUANTITY-labeled glycans ionize easily in MS, which improves their detection sensitivity significantly.
Even though isobaric tags have been widely used for the quantification of peptides and small molecule 
metabolites, previous attempts for glycan quantification have achieved limited success14,15,24. For example, 
aminoxyTMT-labeled glycans need to form metal ion adducts to show reporter ions strong enough for 
quantification upon fragmentation, which can cause ion suppression in MS and reduce detection sen-
sitivity (personal communication). This is not surprising because aminoxyTMT and other isobaric tags 
based on tertiary amine were originally designed for peptide quantification. Since glycosidic bonds in 
glycans fragment much easier than peptide bonds, aminoxyTMT-labeled glycans preferably break apart 
between glycan units and are therefore inefficient to generate reporter ions. Our discovery that quater-
nary amine fragments as easily as glycosidic bonds in MS2 has made it possible to develop QUANTITY, 
which enabled us to achieve global profiling of N-glycans from up to four samples simultaneously for 
the first time.
Using QUANTITY, we compared the glycomics of three CHO cell lines, including WT, ST6Gal1(+ ), 
and ST3Gal4(−). CHO cells are the most widely used cell line for the production of recombinant ther-
apeutic proteins. As glycosylation can alter a number of in vivo properties of glycoprotein, engineering 
mammalian cells with various enzymatic activities of the glycosylation pathway to alter the pattern of 
glycoforms is highly desired for a number of biotechnology applications, including monoclonal antibod-
ies and other therapeutic modalities. We found the over-expression of ST6Gal1 indeed boosted protein 
N-glycosylation and led to increased level of sialylation, while the under-expression of ST3Gal4 showed 
opposite effect to less degree.
Our results indicate QUANTITY is a robust tool to investigate the biological functions of protein 
glycosylation and understand their roles in drug discovery and development. For example, the terminal 
sialic acids on N-glycans are well known for their contribution to biological characteristics of many 
glycoproteins, such as stability, solubility, degradation, and antigenicity. They can prevent glycoproteins 
from being recognized and removed by the asialoglycoprotein receptor of hepatocyte cells to improve 
their circulatory lifespan22,25. Thus, maximizing sialic acid content in therapeutic glycoproteins is highly 
desirable by pharmaceutical industry to ensure their quality and consistency. Our study therefore demon-
strates the power of glycomic analysis and provides a guideline for the bioengineering of CHO cells for 
better protein drug production.
Figure 4. MS profiling and MS/MS quantitation of QUANTITY-labeled glycans from ST6Gal1(+) and 
ST3Gal4(−) CHO cells. N-Glycans are extracted using method described in Fig. 1. (a) MS1 spectrum of 
CHO glycans with multiple charges. (b) MS1 spectrum of CHO glycans after converting to single charge 
(Xcalibur). (c) MS2 spectrum of one sialylated glycan, N2H2S. (d) Quantitation using reporter ions from four 
QUANTITY-labeled glycans.
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Because glycans, along with their sialylation level, have such important biological functions, we believe 
QUANTITY, integrated with solid-phase based glycoprotein immobilization for glycopeptide and glycan 
(GIG)26,27, would be a robust tool for both academic research and industrial applications.
Methods
Glycan enrichment using GIG. Materials and Reagents. Sialylglycopeptide (SGP) was pur-
chased from Fushimi Pharmaceutical Co., Ltd. (Marugame, Kagawa, Japan). Spin columns (snap 
cap), AminoLink resin, aminoxyTMTzero, and Zebra desalting columns were purchased from Pierce 
(Thermo Fisher Scientific Inc.; Rockford, IL); Carbograph was purchased from Grace (Deerfield, IL). 
Peptide-N-glycosidase F (PNGase F), denaturing buffer, and reaction buffer G7 were from New England 
BioLabs (Ipswich, MA). F12K (500 mL), FBS (50 mL), NEAA (5 mL), L-glutamine (5 mL), and Blasticidin 
are purchased from Life Technologies (Frederick, MD). Fetuin from fetal bovine serum, p-Toluidine (pT), 
2,5-dihydroxybenzoic acid (DHB), and N,N-dimethylaniline (DMA) were purchased from Sigma-Aldrich 
(St. Louis, MO); μ -Focus MALDI plate and its holder were form Hudson Surface Technology (Forte Lee, 
NJ); Axima Resonance MALDI QIT-TOF mass spectrometry was from Shimadzu Biotech (Columbia, 
MD). Human sera were collected from healthy men with the approval of the Institutional Review Board 
Figure 5. Regulation of sialic acid in CHO by ST6Gal1(+) and ST3Gal4(−). Same amount of proteins are 
used for glycan extraction and labeling. (a) Coomassie blue of CHO cell proteins on WT, ST6Gal1(+ ), and 
ST3Gal4(−); Lectin blot on WT and ST6Gal1 indicates increased sialic acid expression in ST6Gal1 knock-in 
CHO cells. (b) Heatmap of sialylated N-glycans from CHO cell glycoproteins on WT, ST6Gal1(+ ), and 
ST3Gal4(−). Quantitation is obtained from MS2 of QUANTITY-labeled N-glycans. Increase of sialic acid 
expression is observed in ST6Gal1(+ ) while down-regulated expression is observed in ST3Gal4(−), such as 
(c) N2H2S2, (d) FN2H2S2.
www.nature.com/scientificreports/
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of Johns Hopkins University and pooled for use. Experiments were carried out in accordance with 
the IRB approved guidelines; all experimental protocols were approved by the IRB of Johns Hopkins 
University; informed consent was obtained from all subjects. All other chemicals were purchased from 
Sigma unless specified otherwise.
Wild-Type, ST6Gal1 knockin, and ST3Gal4 knockdown of Chinese Hamster Ovary (CHO) cell 
lines. CHO-K1 cells were recently purchased from Life Technologies. All cell lines were grown in F12-K 
medium (Gibco) supplemented with 10% fetal bovine serum (FBS) (Life Technologies) in a humidi-
fied 37 °C incubator with 5% CO2. Cells were seeded into a 6-well plate at appropriate densities and 
transfected 24 h later using Lipofactamine 2000 (Life Technologies), according to the manufacturer’s 
instruction.
Stable single clones were screened using select drugs, followed by lectin blot to evaluate the effect of 
glycosyltransferase expression. As for ST6 plasmid: ST6Gal1 (PubMed Gene ID: 6480) cDNA was pur-
chased from OriGene and subcloned into pEF6/V5-his TOPO TA. For ST3Gal4: there are 6 members in 
ST3 family, we used Crisper to target ST3Gal4 gene in this family (unpublished data).
Before starting the protocol, cell media, PBS, and trypsin were placed in a 37 °C humidified oven. The 
sterile dishes (10 cm in diameter) were used for cell culture. Cells were quickly thawing in 37 °C water 
bath. Cells were transferred to 10 cm sterile dish and washed with F12-K (10% FBS, 1% NEAA, and 1% 
L-glutamine; note add blasticidin (250 μ g in 500 mL F12-K) only for ST6Gal1). Cells were washed using 
10 mL 1x PBS (6× ) before being collected for cell lysate.
Protein immobilization and sialic acid derivatization. Cells were first sonicated for 30 s in RIPA buffer 
at an interval of 30 s on ice for a total of 3 minutes. The RIPA buffer (Life Technologies) of proteins was 
exchanged with pH 10 buffer using Zebra desalting column (Thermo). Protein concentration was meas-
ured by NanoDrop Lite Spectrophotometer (Thermo). Proteins or peptides were conjugated to beads 
using reductive amination. For SGP (1 mg), 200 μ L of AminoLink resin (500 μ L of 50% slurry) was incu-
bated with sample in 500 μ L buffer (pH 10.0) (100 mM sodium citrate and 50 mM sodium carbonate) at 
room temperature for 4 h with mixing. Then 50 μ L of 500 mM NaCNBH3 in DI was added to incubate 
for another 4 h. After rinsing the resin with 500 μ L of 50 mM phosphate buffer (1 × pH 7.4) twice, sample 
on beads were further reduced by adding 50 mM NaCNBH3 in 50 mM PBS at room temperature for 4 h 
with mixing. After incubation, the beads were washed with 1 M Tris-HCl (500 μ L, pH 7.6) twice before 
addition of 500 μ L of 1 M Tris-HCl (pH 7.6) in the presence of 50 mM NaCNBH3 to block the unreacted 
aldehyde sites on the bead surface for 0.5 h. For protein conjugation, 200 μ g of proteins from each CHO 
cell line, 2 mg fetuin or 20 μ L of serum proteins were first denatured in 100 μ L solution consisting of 
10× denaturing buffer (New England Biolabs) and 90 μ L buffer (pH 10.0) for 10 minutes at 100°C before 
following same protocol as that of SGP. The immobilized samples were washed three times with 500 μ L 
of 1 M NaCl and three times with H2O.
To protect the sialic acid groups, glycans on the solid support were incubated with 465 μ L of 
p-toluidine (Sigma) solution (pH 4–6), which consists of 400 μ L p-toluidine, 25 μ L 36–38% HCl, and 
40 μ L EDC (N-(3-dimethylaminopropyl)-N′ -ethylcarbodiimide; 5.6 M; Sigma). Reaction was preceded 
for 3 h or longer (overnight is preferred) at room temperature before the chemicals were washed off from 
the solid support with 500 μ L of 10% formic acid (3× ), 500 μ L of 10% acetonitrile (3× ), 500 μ L of 1 M 
NaCl (3× ) and finally H2O (3× ).
N-Glycan Release. After removing the wash buffer, 2 μ L of PNGase F, 16 μ L G7 (10× ), and 142 μ L DI 
was added to the bead mixture and incubated at 37 °C for overnight to release N-glycans. The eluted 
glycans were purified by Carbograph and SGP glycans were eluted in 1 mL 80% ACN (0.1% formic acid) 
while other N-glycan eluents were dried in vacuum28. The N-glycans were re-suspended in HPLC grade 
of water, 200 μ L for 1 mg fetuin, 100 μ L for serum and 20 μ L for CHO respectively.
QUANTITIY labeling protocol. The dried glycans were re-suspended in reaction solution mixture con-
sisting of anhydrous dimethyl sulfoxide (DMSO) and acetic acid (AA) (7:3, vol) in the presence of 1 M 
NaCNBH3. For fetuin, glycans enriched from respective GIG were placed in four vials with a theoret-
ical ratio of 1:1:3:5 (starting fetuin 200:200:600:1000 μ g). A fixed volume (20:20:60:100) μ L of 100 mM 
QUANTITY (176, 177, 178, and 179) dissolved in the mixture of DMSO and AA (7:3) were added into 
each sample respectively and incubated at 65 °C for 4 h. The reaction was quenched by addition of 2 mL 
water and 2 μ L concentrated formic acid. Samples that were labeled with 4-plex QUANTITY were pooled 
for cleanup by Carbograph. The purified samples were dissolved in 400 μ L of 0.2% formic acid.
Glycans released from 1 mg SGP were purified by Carbograph and eluted in 1000 μ L of 80% ACN 
(0.1% TFA). 40 μ L eluent was used for labeling with QUANTITY. Another 40 μ L SGP was also labeled 
with aminoxyTMTzero using same protocol as that of QUANTITIY (unfortunately, we did follow man-
ufacturer’s protocol to label glycan with TMT. Results showed only a small amount of glycan conjugated. 
So far, method using DMSO-HOAc showed best yield). Serum glycans (from 20 μ L) were labeled using 
same protocol as that of SGP.
Glycans were quantitatively characterized by MALDI and ESI-MS. The details on experiments and 
synthesis of QUANTITY are available in supporting materials.
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